Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomography

Nuclear Medicine and Biology

Volumn 32, Issue 3, 2005, Pages 253-262

  Ishiwata, Kiichi ^a   Tsukada, Hideo ^b   Kubota, Kazuo ^c   Nariai, Tadashi ^d   Harada, Norihiro ^c   Kawamura, Kazunori ^a,e   Kimura, Yuichi ^a   Oda, Keiichi ^a   Iwata, Ren ^f   Ishii, Kenji ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b CENTRAL RESEARCH LABORATORY   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e 141 0032   (Japan)

^f TOHOKU UNIVERSITY   (Japan)

Author keywords

O 11C methyl l tyrosine; Positron emission tomography; Tumor imaging

Indexed keywords

CARBON 11; O METHYLTYROSINE C 11; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN TUMOR; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; MALE; MONKEY; MOUSE; MUTAGENICITY; NONHUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; URINARY TRACT;

EID: 20144386658     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.11.005     Document Type: Article

References (31)

1. K. Kubota From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology Ann. Nucl. Med. 15 2001 471 486
2. R. Kubota, S. Yamada, K. Kubota, K. Ishiwata, N. Tamahashi, and T. Ido Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J. Nucl. Med. 33 1992 1972 1980
3. 11C]methionine Jpn. J. Cancer Res. 80 1989 778 782
4. W. Vaalburg, H.H. Coenen, C. Crouzel, P.H. Elsinga, B. Långström, and C. Lemaire Amino acids for the measurement of protein synthesis in vivo by PET Nucl. Med. Biol. 19 1992 227 237
5. P.L. Jager, W. Vaalburg, J. Pruim, E.G.E. de Vries, K.J. Langan, and A. Piers Radiolabeled amino acids: basic aspects and clinical application in oncology J. Nucl. Med. 42 2001 432 445
6. 18F] fluoroethyl)-l-tyrosine for tumor imaging J. Nucl. Med. 40 1999 205 212
7. 18F]fluorophenylalanine Int. J. Radiat. Appl. 38 1987 1033 1038
8. 18F]fluoro- l-proline, radiotracers for PET-investigation of disordered matrix protein synthesis J. Label. Compd. Radiopharm. 42 1999 1135 1144
9. 18F]1-amino-3-fluorocyclobutane-1- carboxylic acid to image brain tumors J. Nucl. Med. 40 1999 331 338
10. 18F]fluoropropyl)-l-tyrosine by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin Appl. Radiat. Isot. 58 2003 685 689
11. 18F]fluoromethyl-l-tyrosine as potential PET tracers for imaging amino acid transport J. Label. Compd. Radiopharm. 46 2002 555 566
12. 18F]fluoromethyl-l-tyrosine as tumor imaging tracers by PET Nucl. Med. Biol. 31 1993 191 198
13. S. Yamada, K. Kubota, R. Kubota, T. Ido, and N. Tamahashi High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue J. Nucl. Med. 36 1995 1301 1306
14. 18F-labeled radiopharmaceuticals J. Radiat. Res. 32 1991 243 261
15. M. Watanabe, H. Okada, K. Shimizu, T. Omura, E. Yoshikawa, and T. Kosugi A high resolution animal PET scanner using compact PS-PMT detectors IEEE Trans. Nucl. Sci. 44 1997 1277 1282
16. 11C]raclopride?: PET studies combined with microdialysis in conscious monkeys Brain Res. 841 1999 160 169
17. T. Fujiwara, S. Watanuki, S. Yamamoto, M. Miyake, S. Seo, and M. Itoh Performance evaluation of a large axial field-of-view PET scanner: SET-2400W Ann. Nucl. Med. 11 1997 307 313
18. M. Defrise, P.E. Kinahan, D.W. Townsend, C. Michel, M. Sibomana, and D.F. Newport Exact and approximate rebinning algorithms for 3-D PET data IEEE Trans. Med. Imaging 16 1997 145 158
19. T. Inoue, K. Koyama, N. Oriuchi, S. Alyafei, Z. Yuan, and H. Suzuki Detection of malignant tumors: whole-body PET with fluorine 18 α-methyl tyrosine versus FDG - preliminary study Radiology 220 2001 54 62
20. 18F]fluoro-l-proline Nucl. Med. Biol. 28 2001 287 292
21. 18F]fluoro-l-proline in urologic tumors J. Nucl. Med. 42 2001 752 754
22. 18F-FDG J. Nucl. Med. 44 2003 533 539
23. K. Ishiwata, K. Kubota, M. Murakami, R. Kubota, T. Sasaki, and S. Ishii Re-evaluation of amino acid-PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J. Nucl. Med. 34 1993 1936 1943
24. 18F]fluorotyrosine, a new PET tracer of protein synthesis J. Nucl. Med. 30 1989 1367 1372
25. 14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET J. Nucl. Med. 29 1988 524 529
26. 18F] fluoroethyl)-l-tyrosine Eur. J. Nucl. Med. Mol. Imaging 30 2003 519 524
27. 18F]fluoro-l-proline Nucl. Med. Biol. 31 2004 67 75
28. 18F α-methyl tyrosine PET studies in patients with brain tumors J. Nucl. Med. 40 1999 399 405
29. 18F]Fluoroethyl)-l-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes Eur. J. Nucl. Med. Mol. Imaging 29 2002 1039 1046
30. 18F]fluoropropyl)-l-tyrosine as an oncologic PET tracer Nucl. Med. Biol. 30 2003 733 739
31. T. Kuwert, C. Morgenroth, B. Woesler, P. Matheja, S. Palkovic, and B. Vollet Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions Eur. J. Nucl. Med. 23 1996 1345 1353